Phase 2 N=370 S. Japonicum and Pregnancy Outcomes
Schistosomiasis
Primary: Mean Newborn Birth Weight — 2.85; 2.85 kilograms — p=0.988
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=288 L-PZQ ODT in Schistosoma Infected Children
Schistosomiasis
Primary: Cohort 1a and Cohort 1b: Number of Participants With Clinical Cure Determined by Kato-Katz Method — 86; 39 Participants
Phase 2 N=444 An Open Label Dose Finding Safety and Efficacy in Children and Infants Infected With Schistosomiasis (S.Mansoni)
Schistosomiasis
Primary: Number of Participants With Clinical Cure Determined by Kato-Katz Method — 51; 43; 47; 46 Participants
Phase 2 N=354 Praziquantel in Children Under Age 4
Schistosomiasis · Schistosomiasis Mansoni · Schistosoma Japonicum Infection
Primary: Treatment Efficacy — 96; 98; 96; 98 percentage change
Phase 1 N=45 Safety, Tolerability, and Immunogenicity Study of Sm-p80 + GLA-SE (SchistoShield(R)) Vaccine in Healthy Adults
Schistosomiasis
Primary: Number of Participants Reporting Serious Adverse Events (SAEs) Throughout the Study — 0; 0; 0; 0 Participants
N/A N=978 Health Education Model Led by Community Health Volunteers.
Schistosomiasis · Health Education
Primary: Change in Infection Rate — 47; 35; 3; 6 Number of Participants with S. haematobi
Phase 3 N=356,912 Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH)
Helminthiasis · Filariasis
Primary: Comparison of Arms - Benin — 322; 748; 11; 11 Participants